FrancophonIA/ELRC3.0 huggingface dataset:
English: A study by Haritova et al (2011)11 demonstrated that when E.coli O78/H12 infected chickens (MIC 0.01 µg/ml) were treated with either 10 mg/kg bw or 50 mg/kg bw enrofloxacin for 3 days, both dose
Estonian: Haritova et al (2011)11 uuring näitas, et kui E. coli tüvega O78/H12 nakatatud kanu (MIC 0,01 µg/ml) raviti 3 päeva vältel enrofloksatsiini annustega 10 mg/kg kehamassi kohta ja 50 mg/kg kehamassi kohta, siis kontrollisid mõlemad annused küll kliinilisi haigusnähte, ent haigustekitaja oli 50 mg/kg kehamassi kohta rühmas kuni 25 päeva vältel pärast ravi taastuvastatav üksnes põrnakoest, samas kui 10 mg/kg kehamassi kohta rühmas oli haigustekitaja sama ajavahemiku vältel tuvastatav kopsu-, maksa-, südame- ja põrnakoest.
English: Pigs, calves, chicken (broilers), turkeys
Estonian: Sead, vasikad, kanad (broilerid), kalkunid
English: Four experimental studies which used a variety of different doses were submitted in support of the indication for P.multocida in turkeys.
Estonian: P. multocida põhjustatud infektsioonide ravi näidustuse toetuseks kalkunitel esitati andmed neljast eksperimentaalsest uuringust, milles oli kasutatud väga varieeruvaid annuseid.
English: Chickens and rabbits
Estonian: Kanad and küülikud
English: Broiler
Estonian: Broilerid
English: Adequate data have been submitted to support indications for M.gallisepticum, M.synoviae, A.paragallinarium, P.multocida and E.coli in chickens and M.gallisepticum, M.synoviae, P.multocida and E.coli in turkeys.
Estonian: M. gallisepticum'i, M. synoviae, A. paragallinarium'i, P. multocida ja E. coli põhjustatud infektsioonide ravi näidustusel kanadel ning M. gallisepticum'i, M. synoviae, P. multocida ja E. coli põhjustatud infektsioonide ravi näidustusel kalkunitel on esitatud piisavalt andmeid.
English: Netherlands Laboratorios Karizoo S.A., Pol. Ind. La Borda,
Estonian: Madalmaad Laboratorios Karizoo S.A., Pol. Ind. La Borda,
English: Germany Laboratorios Karizoo S.A., Pol. Ind. La Borda,
Estonian: Saksamaa Laboratorios Karizoo S.A., Pol. Ind. La Borda,
English: There are adequate data to support the indication of Mycoplasma spp in turkeys, based on the fact that they are considered a minor species and extrapolation can be made from the data in chickens.
Estonian: põhjustatud infektsioonide ravi näidustuse toetuseks kalkunitel on piisavad, kui arvestada, et kalkunid on vähemlevinud kodulindude liik, kelle puhul on lubatav kanadel saadud andmete ülekandmine antud liigile.
English: Chicken broiler
Estonian: Broiler Kanad
English: Bayer Animal Health GmbH, 51368 Leverkusen, Germany
Estonian: Bayer Animal Health GmbH, 51368 Leverkusen, Saksamaa
English: Germany Global Vet Health S.L.
Estonian: Saksamaa Global Vet Health S.L.
English: Broilers, rearing poultry, turkeys
Estonian: Broilerid, kodulinnud, kalkunud
English: Universal Farma, S.L., Gran Via Carlos III 98 - 7a, 08028 Barcelona Spain
Estonian: Universal Farma, S.L., Gran Via Carlos III, 98-7a, 08028 Barcelona Hispaania
English: LABORATORIOS E INDUSTRIAS IVEN, S.A. C/Luis I 56
Estonian: Hispaania LABORATORIOS E INDUSTRIAS IVEN, S.A.
English: Germany Vetpharma Animal Health S.L.,
Estonian: Saksamaa Vetpharma Animal Health S.L.,
English: Lithuania Laboratorios Hipra S.A. Avda.
Estonian: Slovakkia Laboratorios Hipra S.A. Avda.
English: Netherlands S.P. VETERINARIA, S.A. Ctra.
Estonian: Madalmaad S.P. VETERINARIA, S.A. Ctra.
English: The indication for treatment of salmonella infections should be removed from the SPCs due to the lack of support for the dosing regimen, especially in regards to elimination of infection, and EU legislation in regards to national control programmes for the control of salmonella in poultry that state that antimicrobials should not be used except in exceptional circumstances (Regulation EC 1177/2006).
Estonian: Euroopa Liidu seadusandlus ütleb riiklike Salmonella kontrollimise programmide osas kodulindudel, et mikroobivastaseid ravimeid võib kasutada üksnes erandlikel asjaoludel (Euroopa Komisjoni määrus nr 1177/2006).
English: Romania Bayer Animal Health GmbH, 51368 Leverkusen,
Estonian: Rumeenia Bayer Animal Health GmbH, 51368 Leverkusen,
English: Cattle (calves), pigs, chicken (broilers), cats, dogs
Estonian: Veised (vasikad), sead, kanad (broilerid), kassid, koerad
English: Pig, chicken (broilers and laying hens) and pigeon
Estonian: Sead, kanad (broilerid ja munevad kanad) ja tuvid
English: Belgium S.P. VETERINARIA, S.A. Ctra.
Estonian: Hispaania S.P. VETERINARIA, S.A. Ctra.
English: Chickens, turkeys and rabbits
Estonian: Kanad, kalkunid ja küülikud
English: Chickens, turkeys, guinea fowl, ducks, pheasant, quails, rabbits
Estonian: Kanad, kalkunid, pärlkanad, pardid, faasanid, vutid, küülikud
English: Lithuania Krka d.d.
Estonian: Sloveenia Krka d.d.
English: Calves, pigs, dogs, cats, chickens (broilers), pigeons
Estonian: Vasikad, sead, koerad, kassid, kanad (broilerid), tuvid
English: Ireland Universal Farma, S.L., Gran Via Carlos III, 98-7a, 08028 Barcelona
Estonian: Hispaania Universal Farma, S.L., Gran Via Carlos III 98 - 7a, 08028 Barcelona
English: Solution for oral use
Estonian: Lahus suukaudseks kasutamiseks
English: Poultry (broilers and fattened turkeys), rabbits
Estonian: Kodulinnud (broilerid ja nuumkalkunid), küülikud
English: Germany Laboratorios Hipra S.A. Avda.
Estonian: Saksamaa Laboratorios Hipra S.A. Avda.
English: • due to the lack of support for the dosing regimen, especially in regards to elimination of infection, and EU legislation in regards to national control programmes for the control of salmonella in poultry that state that antimicrobials should not be used except in exceptional circumstances (Regulation EC 1177/2006), the CVMP considered that the indication for treatment of salmonella infections should be removed from the SPCs;
Estonian: Pealegi ütleb Euroopa Liidu seadusandlus riiklike Salmonella kontrollimise programmide osas kodulindudel, et mikroobivastaseid ravimeid võib kasutada üksnes erandlikel asjaoludel (Euroopa Komisjoni määrus nr 1177/2006);
English: Swine, cattle (calves), broiler chickens, dogs, cats
Estonian: Sead, veised (vasikad), broilerkanad, koerad, kassid
English: Chickens (broilers, replacement chickens, broiler breeders) and rabbits
Estonian: Kanad (broilerid, asenduskanad, tõubroilerid) ja küülikud
English: Chickens, turkeys, rabbits
Estonian: Kanad, kalkunid, küülikud
English: Chicken, turkey, pigeons, cattle, swine, dogs and cats
Estonian: Kanad, kalkunid, tuvid, veised, sead, koerad ja kassid
English: No abnormal findings were present according to palpation of the examined joints and articular cartilage surface.
Estonian: Uuritud liigeste palpatsioonil ja liigeste kõhrepindade uurimisel normist kõrvalekalduvaid muutusi ei täheldatud.
English: Oral solution for use in drinking water
Estonian: Suukaudne lahus joogivees kasutamiseks
English: This would indicate that suitable levels are not reached in lung tissue for efficacy against Mycoplasma spp with an MIC of ≥1 µg/ml.
Estonian: vastase efektiivsuse tagamiseks (MIC väärtus ≥ 1 µg/ml) piisavat enrofloksatsiini sisaldust.
English: Chicken, cattle, swine, pigeons, dogs and cats
Estonian: Kanad, veised, sead, tuvid, koerad ja kassid
English: One field study was submitted to support the indication of P.multocida using an inclusion rate of
Estonian: P. multocida põhjustatud infektsioonide ravi näidustusel esitati üks väliuuring, milles oli kasutatud infusiooni kiirusega 50 ppm.
English: Poultry (broilers, replacement chickens, broiler breeders and turkeys)
Estonian: Kodulinnud (broilerid, asenduskanad, tõubroilerid ja kalkunid)
English: Cattle, pig, dog, chicken, turkey and pigeon
Estonian: Veised, sead, koerad, kanad, kalkunid ja tuvid
English: Chickens (broilers, broiler breeders, replacement chickens), turkeys
Estonian: Kanad (broilerid, tõubroilerid, asenduskanad), kalkunid
English: Two experimental and two field studies were submitted in support of the indication for E.coli.
Estonian: E. coli põhjustatud infektsioonide ravi näidustuse toetuseks esitati kaks eksperimentaalset uuringut ja kaks väliuuringut.
English: Belgium Global Vet Health S.L.
Estonian: Bulgaaria Global Vet Health S.L.
English: Chickens (broilers and breeders), turkeys
Estonian: Kanad (broilerid ja tõukanad), kalkunid
English: http://www.efsa.europa.eu/en/scdocs/doc/1372.pdf 16 Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q (2009) Antibiotic resistance in Campylobacter:
Estonian: Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q (2009) Antibiotic resistance in Campylobacter: emergence, transmission and persistence.
English: Chickens (broilers, replacement chickens, broiler breeders) and turkeys
Estonian: Kanad (broilerid, asenduskanad, tõubroilerid) ja kalkunid
English: Calves, lambs, kids, piglets, poultry, dogs, cats
Estonian: Vasikad, lambad, talled, põrsad, kodulinnud, koerad, kassid
English: Chicken and turkeys
Estonian: Kanad ja tuvid
English: Denmark Bayer Animal Health GmbH, 51368 Leverkusen,
Estonian: Bulgaaria Bayer Animal Health GmbH, 51368 Leverkusen,
English: Enrofloxacin 10% Solution for oral use
Estonian: Enrofloxacin 10% Lahus suukaudseks kasutamiseks
English: Netherlands Krka d.d.
Estonian: Madalmaad Krka d.d.
English: A comprehensive review of data regarding resistance in E.coli, Salmonella sp and Campylobacter spp (bacteria of concern to human health) from poultry from EU Member States isolated during 2002-2009 was provided.
Estonian: (inimtervise aspektist murettekitavad bakterid) resistentsuse kohta Euroopa Liidus aastatel 2002-2009 kodulindudelt kindlakstehtud tüvede alusel.
English: Belgium Vetpharma Animal Health S.L.,
Estonian: Slovakkia Vetpharma Animal Health S.L.,
English: administration of the same dose rate.
Estonian: kehamassi kohta oli efektiivsem kui sama annuse manustamine pulssravina.
English: Both proprietary and published data were provided to form a picture of the depletion of residues from edible tissues resulting from treatment with enrofloxacin-containing, orally-administered veterinary
Estonian: Esitati nii müügiloa hoidjate andmed kui ka kirjanduses avaldatud andmed veterinaarravimi jääkide vähenemise kohta söödavates kudedes pärast kanade ja kalkunite ravimist suukaudselt manustatavate enrofloksatsiini sisaldavate veterinaarravimitega annuses 10 mg/kg kehamassi kohta 5 järjestikusel päeval.
English: Chicken (broilers, replacement chickens, broiler breeders), rabbit
Estonian: Kanad (broilerid, asenduskanad, tõubroilerid), küülikud
English: Oral solution to be administered in drinking water
Estonian: Suukaudne lahus joogivees manustamiseks
English: Chicken, cattle, pig, dog, cat and pigeon
Estonian: Kanad, veised, sead, koerad, kassid ja tuvid
English: Chicken - broilers and turkey
Estonian: Kanad - broilerid ja kalkunid
English: Concentrate for oral solution for use in drinking water
Estonian: Suukaudse lahuse kontsentraat joogivees kasutamiseks
English: Chicken, turkey and pigeon
Estonian: Kanad, kalkunid ja tuvid
English: Chicken (broilers, broiler parent animals, pullets), rabbit
Estonian: Kanad (broilerid, tõubroilerid, noorkanad), küülikud
English: The full EPAR for Entecavir Accord can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst ravimi Entecavir Accord kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: It can also be considered for children aged from 2 to 18 years but only in those with compensated liver disease.
Estonian: Ravimi kasutamist võib kaalutleda ka 2-18-aastastel lastel, kuid üksnes kompenseeritud maksahaiguse korral.
English: The 0.5 mg dose can be taken with or without food, but the 1 mg dose must be taken at least 2 hours before or 2 hours after a meal.
Estonian: 0,5 mg annust tohib võtta koos toiduga või ilma, kuid 1 mg annus tuleb võtta vähemalt 2 tundi enne või 2 tundi pärast sööki.
English: What measures are being taken to ensure the safe and effective use of Entecavir Accord?
Estonian: Mis meetmed võetakse, et tagada ravimi Entecavir Accord ohutu ja efektiivne kasutamine?
English: The treatment duration is determined by how the patient responds.
Estonian: Ravi kestus määratakse patsiendi ravivastuse järgi.
English: Entecavir Accord can only be obtained with a prescription and is available as tablets (0.5 mg and 1 mg).
Estonian: Entecavir Accord on retseptiravim ja seda turustatakse tablettidena (0,5 mg ja 1 mg).
English: Entecavir stops the virus making DNA, and prevents it from multiplying and spreading.
Estonian: Entekaviir peatab viiruse DNA tekke ning takistab viiruse paljunemist ja levikut.
English: Entecavir Accord entecavir
Estonian: Entecavir Accord entekaviir
English: The 1 mg daily dose is also used in adults with decompensated liver disease and stopping treatment is not recommended in these patients.
Estonian: Annust 1 mg ööpäevas kasutatakse ka dekompenseeritud maksahaigusega patsientidel ja nendel patsientidel ei soovitata ravi katkestada.
English: The European Medicines Agency concluded that, in accordance with EU requirements, Entecavir Accord has been shown to have comparable quality and to be bioequivalent to Baraclude.
Estonian: Euroopa Ravimiamet järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud ravimi Entecavir Accord võrreldav kvaliteet ja bioekvivalentsus ravimiga Baraclude.
English: It is used in adults with signs of ongoing liver injury (such as inflammation and fibrosis) when the liver is still working properly (compensated liver disease) and also when the liver is no longer working properly (decompensated liver disease).
Estonian: Seda kasutatakse täiskasvanutel, kellel on jätkuva maksakahjustuse sümptomid (nt põletik ja fibroos), kui maksatalitlus on veel korras (kompenseeritud maksahaigus) ja kui maksatalitlus ei ole enam korras (dekompenseeritud maksahaigus).
English: Entecavir Accord is taken once a day.
Estonian: Ravimit Entecavir Accord võetakse üks kord ööpäevas.
English: For adults with compensated liver disease, the dose depends on whether or not the patient has been previously treated with a medicine in the same group as Entecavir Accord (a nucleoside analogue, such as lamivudine).
Estonian: Kompenseeritud maksahaigusega täiskasvanutel sõltub annus sellest, kas patsienti on või ei ole varem ravitud ravimiga, mis kuulub ravimiga Entecavir Accord samasse rühma (nukleosiidianaloogid, näiteks lamivudiin).
English: Patients who have not been treated before with a nucleoside analogue receive a 0.5 mg dose, while those who have received lamivudine before but whose infection is no longer responding to it are given a 1 mg dose.
Estonian: Patsientidel, keda ei ole varem ravitud nukleosiidianaloogiga, kasutatakse 0,5 mg annust, kuid nendel varem lamivudiiniga ravitud patsientidel, kelle infektsioon (nakkus) ravile enam ei reageeri, kasutatakse 1 mg annust.
English: When treatment is considered appropriate in children, the dose depends on their body weight.
Estonian: Kui laste ravi peetakse vajalikuks, sõltub annus kehamassist.
English: As for every medicine, the company provided studies on the quality of Entecavir Accord.
Estonian: Nagu iga ravimi korral, esitas ettevõte uuringud ravimi Entecavir Accord kvaliteedi kohta.
English: This means that Entecavir Accord contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Baraclude.
Estonian: See tähendab, et Entecavir Accord sisaldab sama toimeainet ja toimib samal viisil kui võrdlusravim Baraclude, millel juba on Euroopa Liidus müügiluba.
English: Entecavir Accord is a medicine used to treat chronic (long-term) hepatitis B (an infectious disease of the liver, caused by the hepatitis B virus).
Estonian: Entecavir Accord on ravim, mida kasutatakse kroonilise (pikaajalise) B-hepatiidi (B-hepatiidi viiruse põhjustatud nakkuslik maksahaigus) raviks.
English: Treatment with Entecavir Accord should be started by a doctor with experience in the management of chronic hepatitis B.
Estonian: Ravi ravimiga Entecavir Accord peab alustama kroonilise B-hepatiidi ravis kogenud arst.
English: Children weighing 32.6 kg and above can be given the 0.5 mg tablets, while an oral solution of entecavir may be available for children weighing less than 32.6 kg. For further information, see the package leaflet.
Estonian: Vähemalt 32,6 kg lastele tohib anda 0,5 mg tablette, kuid alla 32,6 kg lastele võidakse turustada entekaviiri suukaudset lahust.
English: What is Entecavir Accord and what is it used for?
Estonian: Mis on Entecavir Accord ja milleks seda kasutatakse?
English: Studies on the benefits and risks of the active substance in the approved uses have already been carried out with the reference medicine, Baraclude, and do not need to be repeated for Entecavir Accord.
Estonian: Võrdlusravimiga Baraclude on juba tehtud toimeaine heakskiidetud kasutusviiside kasulikkuse ja riski uuringud ning neid ei ole vaja ravimiga Entecavir Accord korrata.
English: Because Entecavir Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Estonian: Et Entecavir Accord on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Entecavir Accord have been included in the summary of product characteristics and the package leaflet.
Estonian: Ravimi Entecavir Accord ohutu ja efektiivse kasutamise soovitused ja ettevaatusmeetmed tervishoiutöötajatele ja patsientidele on lisatud ravimi omaduste kokkuvõttesse ja pakendi infolehele.
English: Entecavir Accord contains the active substance entecavir and is a ‘generic medicine'.
Estonian: Entecavir Accord sisaldab toimeainena entekaviiri ja see on geneeriline ravim.
English: Therefore, the Agency's view was that, as for Baraclude, the benefit outweighs the identified risk.
Estonian: Seetõttu on amet arvamusel, et nagu ka Baraclude korral, ületab ravimi Entecavir Accord kasulikkus sellega kaasnevad riskid.
English: Other information about Entecavir Accord
Estonian: Muu teave ravimi Entecavir Accord kohta
English: The Agency recommended that Entecavir Accord be approved for use in the EU.
Estonian: Ravimiamet soovitas ravimi Entecavir Accord kasutamise Euroopa Liidus heaks kiita.
English: Why is Entecavir Accord approved?
Estonian: Miks Entecavir Accord heaks kiideti?
English: For practical information about using Entecavir Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate ravimi Entecavir Accord kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: How has Entecavir Accord been studied?
Estonian: Kuidas ravimit Entecavir Accord uuriti?
English: For more information about treatment with Entecavir Accord, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate ravimiga Entecavir Accord toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: This is a summary of the European public assessment report (EPAR) for Entecavir Accord.
Estonian: See on ravimi Entecavir Accord Euroopa avaliku hindamisaruande kokkuvõte.
English: It is not intended to provide practical advice on how to use Entecavir Accord.
Estonian: Hindamisaruandes ei anta ravimi Entecavir Accord kasutamise praktilisi nõuandeid.
English: The active substance in Entecavir Accord, entecavir, is an antiviral belonging to the class of the nucleoside analogues.
Estonian: Ravimi Entecavir Accord toimeaine entekaviir on nukleosiidianaloogide klassi kuuluv viirusvastane ravim.
English: Entecavir interferes with the action of a viral enzyme, DNA polymerase, which is involved in the formation of viral DNA.
Estonian: Entekaviir häirib viiruse DNA tekkel osaleva viirusensüümi DNA-polümeraasi toimet.
English: What are the benefits and risks of Entecavir Accord?
Estonian: Milles seisneb ravimi Entecavir Accord kasulikkus ja mis riskid ravimiga kaasnevad?
English: How does Entecavir Accord work?
Estonian: Kuidas Entecavir Accord toimib?
English: Date of first authorisation: 12 May 1998 Date of latest renewal: 20 May 2008
Estonian: Müügiloa esmase väljastamise kuupäev: 12. mai 1998 Müügiloa viimase uuendamise kuupäev: 20. mai 2008
English: Exelon can be used with food, drink and alcohol.
Estonian: Exelon'i võib kasutada koos toidu, joogi ja alkoholiga.
English: Other medicines and Exelon
Estonian: Muud ravimid ja Exelon
English: For patients starting treatment for the first time and for patients restarting Exelon after treatment interruption, please begin with the second picture.
Estonian: Patsiendid, kes alustavad ravi esimest korda ja patsiendid, kes alustavad Exelon-ravi uuesti pärast katkestamist, alustage palun teisest pildist.
English: Always use Exelon transdermal patches exactly as your doctor has told you.
Estonian: Kasutage Exelon transdermaalseid plaastreid alati täpselt nii, nagu arst on teile selgitanud.
English: Absolute bioavailability after a 3 mg dose is about 36%13%.
Estonian: Absoluutne biosaadavus pärast 3 mg annust on ligikaudu 36%13%.
English: If you accidentally take more Exelon than you should, inform your doctor.
Estonian: Kui te võtate kogemata rohkem Exelon'i kui te peaksite, informeerige sellest oma arsti.
English: Can you wear your Exelon transdermal patch when you are bathing, swimming, or in the sun?
Estonian: Kas Exelon transdermaalseid plaastreid võib kanda vannis käies, ujudes või päevitades?
English: Your doctor will tell you which Exelon transdermal patch is most suitable for you.
Estonian: Arst ütleb, milline Exelon transdermaalne plaaster on teile sobivaim.
English: In other cases, Exelon has been discontinued (see section 4.8).
Estonian: Muudel juhtudel on Exelon'i kasutamine lõpetatud (vt lõik 4.8).
English: • Take Exelon twice a day, in the morning and evening, with food.
Estonian: • Võtke Exelon'i kaks korda päevas toiduga (hommikuti ja õhtuti).
English: Exelon transdermal patches may cause fainting or severe confusion.
Estonian: Exelon transdermaalsed plaastrid võivad põhjustada minestust või tõsist segasust.
English: Like all medicines, Exelon transdermal patches can cause side effects, although not everybody gets them.
Estonian: Nagu kõik ravimid, võivad ka Exelon transdermaalsed plaastrid põhjustada kõrvaltoimeid, kuigi kõigil neid ei teki.
English: Misuse of the medicinal product and dosing errors with Exelon transdermal patch have resulted in serious adverse reactions; some cases have required hospitalisation, and rarely led to death (see section 4.9).
Estonian: Ravimi väärkasutus ja Exelon'i transdermaalsete plaastrite kasutamisvead on viinud tõsiste kõrvaltoimete esinemiseni, mis mõnedel juhtudel on vajanud hospitaliseerimist ja on harva olnud surmaga lõppevad (vt lõik 4.9).
English: It was rated as severe in ≤2.2% of patients in these studies and in ≤3.7% of patients treated with Exelon transdermal patches in a Japanese study.
Estonian: Nendes uuringutes hinnati nahaärritust raskeks ≤2,2%-l patsientidest ning Jaapani uuringus ≤3,7%-l Exelon transdermaalsete plaastritega ravi saanud patsientidest.
English: When and for how long to apply your Exelon transdermal patch
Estonian: Millal ja kui kaua Exelon transdermaalseid plaastreid kasutada
English: What Exelon is and what it is used for
Estonian: Mis ravim on Exelon ja milleks seda kasutatakse
English: Absorption of rivastigmine from Exelon transdermal patches is slow.
Estonian: Rivastigmiini imendumine Exelon transdermaalsetest plaastritest on aeglane.
English: If this applies to you, tell your doctor and do not take Exelon.
Estonian: Kui see kehtib teie kohta, teavitage sellest oma arsti ja ärge Exelon'i võtke.
English: Care must be taken when prescribing Exelon transdermal patches:
Estonian: Ettevaatlik peab olema Exelon transdermaalsete plaastrite määramisel: